Invivyd, Inc. (IVVD)
1.065
-0.06
(-5.75%)
USD |
NASDAQ |
May 19, 15:14
Invivyd Research and Development Expense (Quarterly) : 30.73M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| MannKind Corp. | 17.23M |
| Altimmune, Inc. | 16.17M |
| Cellectar Biosciences, Inc. | 3.007M |
| Karyopharm Therapeutics, Inc. | 33.78M |
| REGENXBIO, Inc. | 53.48M |